As a rare genetic disease, human BTHS studies of myocardial metabolism are limited in nature, and the furthering of our understanding of energy metabolism as a pathological mediator in this disorder will likely come from studies in the TazKD murine mouse model of BTHS (Acehan et al., 2011). This evidence concerns the gene TAFAZZIN and Barth syndrome.